Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Asset Utilization Ratio: 2021-2025

Historic Asset Utilization Ratio for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to 0.76.

  • Xeris Biopharma Holdings' Asset Utilization Ratio rose 31.56% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 31.56%. This contributed to the annual value of 0.63 for FY2024, which is 28.01% up from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Asset Utilization Ratio stood at 0.76 for Q3 2025, which was down 0.23% from 0.76 recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Asset Utilization Ratio ranged from a high of 0.76 in Q2 2025 and a low of 0.20 during Q1 2022.
  • In the last 3 years, Xeris Biopharma Holdings' Asset Utilization Ratio had a median value of 0.54 in 2024 and averaged 0.57.
  • Data for Xeris Biopharma Holdings' Asset Utilization Ratio shows a peak YoY spiked of 84.37% (in 2023) over the last 5 years.
  • Xeris Biopharma Holdings' Asset Utilization Ratio (Quarterly) stood at 0.23 in 2021, then skyrocketed by 49.56% to 0.34 in 2022, then soared by 48.03% to 0.50 in 2023, then grew by 25.08% to 0.63 in 2024, then soared by 31.56% to 0.76 in 2025.
  • Its last three reported values are 0.76 in Q3 2025, 0.76 for Q2 2025, and 0.70 during Q1 2025.